Project
ABIRISK
dc9b062e-147a-11eb-b51f-8c8590c45a21
Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk
Studies
3| Title | Primary purpose | Study type | Organism |
|---|---|---|---|
| ABI-MS | Anti-Biopharmaceutical Immunization: Prediction and analysis of clinical relevance to minimize the risk of immunization in multiple sclerosis patients on interferon-beta treatment | observational | Homo sapiens |
| ABI-RA | Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients (ABI-RA) | observational | Homo sapiens |
| ABI-IBD | Anti-Biopharmaceutical Immunization : Prediction and analysis of clinical relevance to minimize the risk in Inflammatory bowel disease (IBD) | observational | Homo sapiens |
Datasets
1| Accession | Title | Created | Study | hosted at UL |
|---|---|---|---|---|
| 6bd9243b-0368-4cc9-bc92-d00ba1d40b75 | Genotyping of ABIRISK cohorts | 2016-04-01 | - | No |
Publications
7- http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0162752
- https://pubmed.ncbi.nlm.nih.gov/25959571
- https://pubmed.ncbi.nlm.nih.gov/33125391
- https://pubmed.ncbi.nlm.nih.gov/30447419
- https://pubmed.ncbi.nlm.nih.gov/31194850
- https://pubmed.ncbi.nlm.nih.gov/30420245
- https://pubmed.ncbi.nlm.nih.gov/29875313